keyword
https://read.qxmd.com/read/38544834/mapping-breast-and-prostate-cancer-in-the-brazilian-public-health-system-study-protocol-of-the-onco-genomas-brasil
#21
JOURNAL ARTICLE
Jaqueline Bohrer Schuch, Cláudia Bordignon, Mahira Lopes Rosa, Angélica Cerveira de Baumont, Marina Bessel, Gabriel S Macedo, Daniela Dornelles Rosa
BACKGROUND: Breast and prostate cancers are the most common malignancies diagnosed in women and men respectively, and present with great clinical heterogeneity, even in tumors with the same histology and same site of origin. Somatic and germline molecular alterations in DNA may have prognostic and predictive impact, influencing response to therapies and overall survival. Our aim is to characterize the somatic and germline genomic landscape of women with locally advanced HER2-positive breast cancer and men with metastatic prostate cancer in Brazil...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38542413/onco-hypertension-a-continuously-developing-field-between-cancer-and-hypertension
#22
REVIEW
Stefan Totolici, Ana-Maria Vrabie, Elisabeta Badila, Emma Weiss
The prognosis of cancer patients has greatly improved in the last years, owing to the development of novel chemotherapeutic agents. However, this progress comes with an increasing occurrence of cardiovascular adverse reactions. A serious side effect is arterial hypertension (HT), which is the most frequent comorbidity encountered in cancer patients, influencing the outcomes in cancer survivors. Even though secondary HT related to specific chemotherapeutic agents, such as vascular endothelial growth factor inhibitors, is usually mild and reversible, in rare instances it can be severe, leading to discontinuation of chemotherapy...
March 19, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38541221/disseminated-enterovirus-infection-in-a-patient-affected-by-follicular-lymphoma-treated-with-obinutuzumab-a-case-report-and-a-narrative-review-of-the-literature
#23
REVIEW
Tommaso Lupia, Silvia Corcione, Elena Staffilano, Roberta Bosio, Antonio Curtoni, Alessandro Busca, Francesco Giuseppe De Rosa
Background and Objectives : the principal purpose of this literature review is to cluster adults with hematological malignancies after treatment or on maintenance with obinutuzumab who experienced disseminated EV infection to understand clinical characteristics and outcome of this rare condition in these patients. We report the first clinical case of a male affected by follicular lymphoma treated with immune-chemotherapy including obinutuzumab who was affected by disseminated EV infection with cardiovascular involvement...
March 18, 2024: Medicina
https://read.qxmd.com/read/38536399/characteristics-of-enterococcus-species-bloodstream-infections-among-adults-with-and-without-onco-hematological-malignancies-experiences-from-the-national-center-of-hungary
#24
JOURNAL ARTICLE
Bence Marosi, Béla Kádár, Anna Bruzsa, Laura Kocsis, Katalin Kamotsay, János Sinkó, Bálint Gergely Szabó, Botond Lakatos
INTRODUCTION: Over the past decade, enterococcal bloodstream infection (BSI) shows increasing incidence globally among the elderly and in patients with comorbidities. In this study, we aimed to assess microbiological and clinical characteristics and long-term outcomes of BSIs caused by Enterococcus spp. in adult patients with and without active onco-hematological malignancies hospitalized at a national referral institute. METHODS: A prospective analysis of consecutive enterococcal BSI cases was conducted in the National Institute of Hematology and Infectious Diseases (Budapest, Hungary) between December 2019 and April 2022...
March 27, 2024: European Journal of Microbiology & Immunology
https://read.qxmd.com/read/38535200/a-phase-i-iia-prospective-randomized-open-label-study-on-the-safety-and-efficacy-of-nebulized-liposomal-amphotericin-for-invasive-pulmonary-aspergillosis
#25
JOURNAL ARTICLE
Jesús Fortún, Elia Gómez-García de la Pedrosa, Alberto Martínez-Lorca, Patricia Paredes, Pilar Martín-Dávila, Alicia Gómez-López, María José Buitrago, Javier López-Jiménez, Francesca Gioia, Rosa Escudero, Maria Elena Alvarez-Alvarez, Cruz Soriano, Javier Moreno-García, Diana San Miguel, Noelia Vicente, Santiago Moreno
Although nebulized liposomal amphotericin B (NLAB) is being used in invasive pulmonary aspergillosis (IPA) prophylaxis, no clinical trial has shown its efficacy as a therapeutic strategy. NAIFI is the inaugural randomized, controlled clinical trial designed to examine the safety and effectiveness of NLAB (dosage: 25 mg in 6 mL, three times per week for 6 weeks) against a placebo, in the auxiliary treatment of IPA. Throughout the three-year clinical trial, thirteen patients (six NLAB, seven placebo) were included, with 61% being onco-hematological with less than 100 neutrophils/μL...
March 1, 2024: Journal of Fungi (Basel, Switzerland)
https://read.qxmd.com/read/38521164/electrochemical-immunosensing-of-tumor-markers
#26
REVIEW
Venkata Narayana Palakollu, Y Veera Manohara Reddy, Mehdihasan I Shekh, S V Prabhakar Vattikuti, Jaesool Shim, Rajshekhar Karpoormath
The rising incidence and mortality rates of cancer have led to a growing need for precise and prompt early diagnostic approaches to effectively combat this disease. However, traditional methods employed for detecting tumor cells, such as histopathological and immunological techniques, are often associated with complex procedures, high analytical expenses, elevated false positive rates, and a dependence on experienced personnel. Tracking tumor markers is recognized as one of the most effective approaches for early detection and prognosis of cancer...
March 21, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38521118/subclinical-myocardial-damage-after-anthracycline-chemotherapy-in-japanese-patients-with-breast-cancer
#27
JOURNAL ARTICLE
Kenji Nakatsuma, Neiko Ozasa, Mikiko Ohno, Hiroshi Ishiguro, Manabu Minami, Eiichiro Nishi, Masakazu Toi, Koh Ono, Takeshi Kimura
BACKGROUND: Data on the incidence, timing, and severity of myocardial damage after anthracycline-based chemotherapy (AC) in Japanese patients with breast cancer are limited. METHOD: We evaluated cancer therapy-related cardiac dysfunction (CTRCD) in Japanese women with breast cancer (n = 51) after the first AC according to the definitions of the 2022 European Society of Cardiology onco-cardiology guideline, including assessment of high-sensitivity troponin I (TnI) and B-type natriuretic peptide (BNP) levels...
March 21, 2024: Journal of Cardiology
https://read.qxmd.com/read/38515400/metabolic-syndrome-and-cardiovascular-disease-in-cancer-survivors
#28
JOURNAL ARTICLE
Kensuke Ueno, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Kentaro Kamiya, Junya Ako, Koichi Node, Hideo Yasunaga, Issei Komuro
BACKGROUND: The risk of subsequent cardiovascular disease (CVD) is high in cancer survivors. Although metabolic syndrome is an established risk factor for CVD, its association with cancer survivors has not yet been established. This study aimed to clarify whether metabolic syndrome is associated with subsequent CVD risk in patients with cancer using a nationwide epidemiological dataset. METHODS: We retrospectively analysed 53 510 patients with a history of breast, colorectal, or stomach cancer, which is reportedly a major site for developing cancer in Japan...
March 22, 2024: Journal of Cachexia, Sarcopenia and Muscle
https://read.qxmd.com/read/38514800/the-comparative-study-of-chronically-ill-and-healthy-children-and-adolescents-in-the-light-of-their-general-mental-health
#29
JOURNAL ARTICLE
Péter Boris, Karolina Eszter Kovács, Beáta Erika Nagy
Children's hospitalisation is difficult for the family and the immediate environment. In these cases, the provision of psychological support is particularly important. Chronically ill children who are regularly hospitalised are in a particularly difficult situation, often feeling vulnerable. Our research aims to explore and analyse in detail the psychological state, attitudes and mental health of chronically ill children and to compare patient groups (children receiving care in pulmonology, gastroenterology, onco-haematology and rehabilitation) to understand the interacting factors, which may be of great importance for quality patient care and for measures to improve patient care in the future...
March 21, 2024: Scientific Reports
https://read.qxmd.com/read/38493776/onco-hypertension-in-patients-with-kidney-disease
#30
REVIEW
Shubhi Pandey, Simon Kashfi, Susana Hong, Amar Kalaria, Agnes S Kim
BACKGROUND: Cancer, hypertension, and kidney disease are closely interrelated. Knowledge of the potential hypertensive and nephrotoxic effects of antineoplastic medications is critical to minimizing interruptions in cancer treatment. SUMMARY: Antineoplastic medications can cause hypertension, proteinuria, and kidney injury, often mediated by common mechanisms. Notably, inhibitors of the vascular endothelial growth factor pathway have the strongest association with both hypertension and proteinuria, typically acute in onset and often reversible after drug discontinuation...
March 17, 2024: American Journal of Nephrology
https://read.qxmd.com/read/38484373/-neurosurgical-treatment-of-tumors-of-the-pineal-region-literature-review-and-overview-of-cases-at-omiii
#31
JOURNAL ARTICLE
Tamás Mezei, János Báskay, Péter Pollner, Viktória Kovács, Balázs Markia, Gábor Nagy, András Bajcsay, László Sipos
Pineal region tumors account for less than 1% of adult supratentorial tumors. Their treatment requires a multimodality approach. Previously, the treatment of choice was direct surgery, which is associated with high surgical risk. Advances in minimally invasive techniques and onco-radiotherapy offer a safe and multimodal personalized therapy. The aim of our study was to describe the practice of our Institute based on combined endoscopic and radiotherapy techniques. We performed a retrospective clinical study...
March 14, 2024: Magyar Onkologia
https://read.qxmd.com/read/38483752/the-crucial-roles-of-diet-microbiota-and-postbiotics-in-colorectal-cancer
#32
REVIEW
Rüya Kuru-Yaşar, Özlem Üstün-Aytekin
PURPOSE OF REVIEW: Colorectal cancer is the second deadliest cancer in the world, and its prevalence has been increasing alarmingly in recent years. After researchers discovered the existence of dysbiosis in colorectal cancer, they considered the use of probiotics in the treatment of colorectal cancer. However, for various reasons, including the low safety profile of probiotics in susceptible and immunocompromised patient5s, and the risk of developing antibiotic resistance, researchers have shifted their focus to non-living cells, their components, and metabolites...
March 14, 2024: Current Nutrition Reports
https://read.qxmd.com/read/38481729/trial-watch-dexmedetomidine-in-cancer-therapy
#33
REVIEW
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, Lucillia Bezu
Dexmedetomidine (DEX) is a highly selective α2-adrenoceptor agonist that is widely used in intensive and anesthetic care for its sedative and anxiolytic properties. DEX has the capacity to alleviate inflammatory pain while limiting immunosuppressive glucocorticoid stress during major surgery, thus harboring therapeutic benefits for oncological procedures. Recently, the molecular mechanisms of DEX-mediated anticancer effects have been partially deciphered. Together with additional preclinical data, these mechanistic insights support the hypothesis that DEX-induced therapeutic benefits are mediated via the stimulation of adaptive anti-tumor immune responses...
2024: Oncoimmunology
https://read.qxmd.com/read/38466867/efficacy-and-tolerability-of-bacillus-calmette-gu%C3%A3-rin-strain-russia-for-the-treatment-of-non-muscle-invasive-bladder-cancer-analysis-of-a-prospective-registry
#34
JOURNAL ARTICLE
Sarah Flury-Sutter, Frederick Heuzeroth, Emilio Arbelaez, Lukas Bubendorf, Heike Püschel, Stefanie Hayoz, Cyrill A Rentsch
INTRODUCTION: Little is known about the efficacy and tolerability of intravesical bacillus Calmette-Guérin (BCG) strain Russia for treatment of non-muscle-invasive bladder cancer (NMIBC) in a middle- European population. METHODS: A prospective collection of outcomes of 101 BCG-naive patients with urothelial bladder carcinoma was carried out between January 2013 and October 2023 at the University Hospital Basel, Basel, Switzerland. Patients underwent BCG (ONCO-BCGSIIL, Serum Institute of India, Pune, India) induction and a maximum of three maintenance cycles within one year...
March 1, 2024: Canadian Urological Association Journal
https://read.qxmd.com/read/38465861/repression-of-the-sumo-conjugating-enzyme-ubc9-is-associated-with-lowered-double-minutes-and-reduced-tumor-progression
#35
JOURNAL ARTICLE
Yusi Wang, Hongyan Zou, Wei Ji, Min Huang, Benhui You, Nan Sun, Yuandong Qiao, Peng Liu, Lidan Xu, Xuelong Zhang, Mengdi Cai, Ye Kuang, Songbin Fu, Wenjing Sun, Xueyuan Jia, Jie Wu
Double minutes (DMs), extrachromosomal gene fragments found within certain tumors, have been noted to carry onco- and drug resistance genes contributing to tumor pathogenesis and progression. After screening for SUMO-related molecule expression within various tumor sample and cell line databases, we found that SUMO-conjugating enzyme UBC9 has been associated with genome instability and tumor cell DM counts, which was confirmed both in vitro and in vivo . Karyotyping determined DM counts post-UBC9 knockdown or SUMOylation inhibitor 2-D08, while RT-qPCR and Western blot were used to measure DM-carried gene expression in vitro ...
December 31, 2024: Cancer Biology & Therapy
https://read.qxmd.com/read/38462535/home-treatment-for-active-cancer-patients-with-low-risk-pulmonary-embolism%C3%A3-a-predetermined-companion-report-from-the-onco-pe-trial
#36
JOURNAL ARTICLE
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Wataru Shioyama, Tatsuhiro Shibata, Yuji Nishimoto, Yoshito Ogihara, Kosuke Doi, Maki Oi, Taro Shiga, Daisuke Sueta, Kitae Kim, Yasuhiro Tanabe, Norimichi Koitabashi, Takuma Takada, Satoshi Ikeda, Hitoshi Nakagawa, Takayuki Mitsuhashi, Masaaki Shoji, Jiro Sakamoto, Shinji Hisatake, Yutaka Ogino, Masashi Fujita, Naohiko Nakanishi, Tomohiro Dohke, Seiichi Hiramori, Ryuzo Nawada, Kazuhisa Kaneda, Kazunori Mushiake, Hiromi Yamamoto, Kazushige Kadota, Koh Ono, Takeshi Kimura
BACKGROUND: Patients with appropriately selected low-risk pulmonary embolism (PE) can be treated at home, although it has been controversial whether applies to patients with cancer, who are considered not to be at low risk.Methods and Results: The current predetermined companion report from the ONCO PE trial evaluated the 3-month clinical outcomes of patients with home treatment and those with in-hospital treatment. The ONCO PE trial was a multicenter, randomized clinical trial among 32 institutions in Japan investigating the optimal duration of rivaroxaban treatment in cancer-associated PE patients with a score of 1 using the simplified version of the Pulmonary Embolism Severity Index (sPESI)...
March 8, 2024: Circulation Journal: Official Journal of the Japanese Circulation Society
https://read.qxmd.com/read/38461088/-severe-complications-of-systemic-treatment-in-thoracic-oncology
#37
REVIEW
T Berghmans, M Brandão, M Ilzkovitz, A-P Meert
Primary thoracic cancers affect a large number of patients, mainly those with lung cancer and to a lesser extent those with pleural mesothelioma and thymic tumours. Given their frequency and associated comorbidities, in patients whose mean age is high, these diseases are associated with multiple complications. This article, the last of a series dedicated to emergencies in onco-haematological patients, aims to present a clinical picture of the severe complications (side effects, immune-related adverse events) associated with systemic treatments, excluding infections and respiratory emergencies, with which general practitioners and specialists can be confronted...
March 8, 2024: Revue des Maladies Respiratoires
https://read.qxmd.com/read/38454962/pericardial-anisakiasis-unravelling-diagnostic-challenges-in-an-unprecedented-extra-abdominal-manifestation-a-case-report
#38
Jacopo Giovacchini, Silvia Menale, Valentina Scheggi, Niccolò Marchionni
BACKGROUND: Anisakis infects humans by consuming contaminated undercooked or raw fish, leading to gastric anisakiasis, gastro-allergic anisakiasis, or asymptomatic contamination. Although larvae usually die when penetrating the gastric tissue, cases of intra- and extra-abdominal spread were described. We report the first probable case of pericardial anisakiasis. CASE SUMMARY: A 26-year-old man presented to the emergency department because of progressive lower limb oedema and exertional dyspnoea...
March 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38454393/inducing-expression-of-icos-l-by-oncolytic-adenovirus-to-enhance-tumor-specific-bi-specific-antibody-efficacy
#39
JOURNAL ARTICLE
Neshat Saffarzadeh, Emelie Foord, Eoghan O'Leary, Rand Mahmoun, Thomas Birkballe Hansen, Victor Levitsky, Thomas Poiret, Michael Uhlin
BACKGROUND: Intratumoral injection of oncolytic viruses (OVs) shows promise in immunotherapy: ONCOS-102, a genetically engineered OV that encodes Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) demonstrated efficacy in early clinical trials, enhancing T cell infiltration in tumors. This suggests OVs may boost various forms of immunotherapy, including tumor-specific bi-specific antibodies (BsAbs). METHODS: Our study investigated in vitro, how ONCOS-204, a variant of ONCOS-virus expressing the ligand of inducible T-cell co-stimulator (ICOSL), modulates the process of T cell activation induced by a BsAb...
March 7, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38453895/isoform-alterations-in-the-ubiquitination-machinery-impacting-gastrointestinal-malignancies
#40
REVIEW
Srimathi Kasturirangan, Derek J Nancarrow, Ayush Shah, Kiran H Lagisetty, Theodore S Lawrence, David G Beer, Dipankar Ray
The advancement of RNAseq and isoform-specific expression platforms has led to the understanding that isoform changes can alter molecular signaling to promote tumorigenesis. An active area in cancer research is uncovering the roles of ubiquitination on spliceosome assembly contributing to transcript diversity and expression of alternative isoforms. However, the effects of isoform changes on functionality of ubiquitination machineries (E1, E2, E3, E4, and deubiquitinating (DUB) enzymes) influencing onco- and tumor suppressor protein stabilities is currently understudied...
March 8, 2024: Cell Death & Disease
keyword
keyword
39735
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.